Dupilumab Add-on to Medium-dose Inhaled Corticosteroid (ICS) Increases Odds of Asthma Control and Reduces FeNO Compared With Placebo Add-on to High-dose ICS

W. Busse, M. Castro,N.L. Lugogo, P.M. O’Byrne, L.B. Bacharier, C. Xia, M. Hardin, M. Soliman, H. Sacks, J.A. Jacob-Nara,P.J. Rowe, Y. Deniz

C34. BIOLOGIC THERAPY IN THE FIGHT AGAINST ASTHMA AND ALLERGIC INFLAMMATION（2024）

引用 0|浏览0